Subscribe
Numstocker / Shutterstock.com
27 May 2025NewsEuropeMarisa Woutersen

Moderna entities must face infringement suits, UPC rules

UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Patent pledges in global crises: Why Moderna prevailed over Pfizer/BioNTech
10 April 2025   The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder that it is risky to rely solely on informal public declarations, say Ina vom Feld and Maximilian Kücking of Herbert Smith Freehills.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.
Americas
Moderna wins reprieve in COVID-19 vaccine dispute
3 October 2024   Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Europe
Patent pledges in global crises: Why Moderna prevailed over Pfizer/BioNTech
10 April 2025   The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder that it is risky to rely solely on informal public declarations, say Ina vom Feld and Maximilian Kücking of Herbert Smith Freehills.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.
Americas
Moderna wins reprieve in COVID-19 vaccine dispute
3 October 2024   Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

More on this story

Europe
Patent pledges in global crises: Why Moderna prevailed over Pfizer/BioNTech
10 April 2025   The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder that it is risky to rely solely on informal public declarations, say Ina vom Feld and Maximilian Kücking of Herbert Smith Freehills.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.
Americas
Moderna wins reprieve in COVID-19 vaccine dispute
3 October 2024   Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

More features

Fed Circ refuses to stay Novartis feud with MSN over Entresto
Baker McKenzie adds London partner with ‘enviable’ expertise
‘Keep calm and carry on’: UK+ regime stays post-Brexit
As AI shakes up pharma and biotech, can patent law keep up?
UK court clears the way for Amgen and Samsung to launch biosimilars
SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute
‘It’s going to be very different’: INTA CEO shares London meeting plans
'Scrap the billable hour': LSIPR joins INTA panel on gender diversity